Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -15.55M
March 31, 2026 -15.55M
December 31, 2025 -15.55M
September 30, 2025 -0.0426M
June 30, 2025 -0.0502M
March 31, 2025 -0.0509M
December 31, 2024 -0.055M
September 30, 2024 -0.0619M
June 30, 2024 -0.0549M
March 31, 2024 -0.0571M
December 31, 2023 -0.0551M
September 30, 2023 -0.0477M
June 30, 2023 -1.796M
March 31, 2023 -1.745M
December 31, 2022 -1.770M
September 30, 2022 -4.606M
June 30, 2022 -2.854M
March 31, 2022 -3.999M
December 31, 2021 -3.982M
September 30, 2021
June 30, 2021
March 31, 2021
September 30, 2010
September 30, 2007
June 30, 2007 -0.5624M
Date Value
March 31, 2007 -0.5661M
December 31, 2006 -0.5744M
September 30, 2006 -0.5655M
June 30, 2006 -0.1458M
March 31, 2006 -0.1861M
December 31, 2005 -0.333M
September 30, 2005 -0.445M
June 30, 2005 -1.118M
March 31, 2005 -1.167M
December 31, 2004 -1.145M
September 30, 2004 -0.9444M
June 30, 2004 -0.4408M
March 31, 2004 -0.5171M
December 31, 2003 -0.3261M
September 30, 2003 -0.1527M
June 30, 2003 0.0648M
March 31, 2003 -0.0909M
December 31, 2002 -0.30M
September 30, 2002 -0.5598M
June 30, 2002 -0.6667M
March 31, 2002 -0.3979M
December 31, 2001 -0.1337M
September 30, 2001 -0.0969M
June 30, 2001 0.0488M
March 31, 2001 0.0441M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Biomerica, Inc. -3.422M
Lantheus Holdings, Inc. 382.42M
Zomedica Corp. -14.80M
IDEXX Laboratories, Inc. 1.233B
Neogen Corp. 31.90M